Targeted anti-apoptosis activity for ovarian protection against chemotherapy-induced ovarian gonadotoxicity

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Chemotherapy damages the reproductive system by enhancing apoptosis, and evidence suggests that targeted anti-apoptotic therapy may preserve fertility in patients receiving chemotherapy. To investigate the protective effect of sphingosine-1-phosphate (S1P) on chemotherapeutic agent-induced ovarian gonadotoxicity, busulfan-treated female mice were pre-treated with low (0.5 mM) and high (2.0 mM) doses of S1P or vehicle 1 h before busulfan injection. In the S1P groups, each mouse was injected with low-dose S1P in one ovary and high-dose S1P in the contralateral ovary. Four weeks later, the ovaries were removed for histological and biochemical examinations. Caspase 3 immunoreactivity was greater in mice treated with busulfan compared with mice pre-treated with S1P, in which more primordial follicles were observed (P <0.05). The mRNA level of anti-Müllerian hormone was higher in mice pre-treated with S1P than those that received busulfan only, indicating a better ovarian function in mice pre-treated with S1P. No difference was observed in the levels of growth differentiation factor-9 among all groups. In conclusion, S1P protects primordial follicles from chemotherapy-induced gonadotoxicity, and may partially preserve ovarian function.

Original languageEnglish
Pages (from-to)612-620
Number of pages9
JournalReproductive BioMedicine Online
Volume29
Issue number5
DOIs
Publication statusPublished - Nov 1 2014

Fingerprint

Apoptosis
Drug Therapy
Busulfan
Ovary
Growth Differentiation Factor 9
sphingosine 1-phosphate
Caspase 3
Fertility
Hormones
Messenger RNA
Injections

Keywords

  • anti-apoptotic therapy
  • anti-Müllerian hormone
  • caspase-3
  • fertility preservation
  • gonadotoxicity
  • sphingosine-1-phosphate

ASJC Scopus subject areas

  • Reproductive Medicine
  • Developmental Biology
  • Medicine(all)

Cite this

@article{5323074da6084d79950760827ff651c4,
title = "Targeted anti-apoptosis activity for ovarian protection against chemotherapy-induced ovarian gonadotoxicity",
abstract = "Chemotherapy damages the reproductive system by enhancing apoptosis, and evidence suggests that targeted anti-apoptotic therapy may preserve fertility in patients receiving chemotherapy. To investigate the protective effect of sphingosine-1-phosphate (S1P) on chemotherapeutic agent-induced ovarian gonadotoxicity, busulfan-treated female mice were pre-treated with low (0.5 mM) and high (2.0 mM) doses of S1P or vehicle 1 h before busulfan injection. In the S1P groups, each mouse was injected with low-dose S1P in one ovary and high-dose S1P in the contralateral ovary. Four weeks later, the ovaries were removed for histological and biochemical examinations. Caspase 3 immunoreactivity was greater in mice treated with busulfan compared with mice pre-treated with S1P, in which more primordial follicles were observed (P <0.05). The mRNA level of anti-M{\"u}llerian hormone was higher in mice pre-treated with S1P than those that received busulfan only, indicating a better ovarian function in mice pre-treated with S1P. No difference was observed in the levels of growth differentiation factor-9 among all groups. In conclusion, S1P protects primordial follicles from chemotherapy-induced gonadotoxicity, and may partially preserve ovarian function.",
keywords = "anti-apoptotic therapy, anti-M{\"u}llerian hormone, caspase-3, fertility preservation, gonadotoxicity, sphingosine-1-phosphate",
author = "Tan, {Shun Jen} and Lee, {Li Jen} and Tzeng, {Chii Ruey} and Chia-Woei Wang and Hsu, {Ming I.} and Chen, {Chi Huang}",
year = "2014",
month = "11",
day = "1",
doi = "10.1016/j.rbmo.2014.07.014",
language = "English",
volume = "29",
pages = "612--620",
journal = "Reproductive BioMedicine Online",
issn = "1472-6483",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Targeted anti-apoptosis activity for ovarian protection against chemotherapy-induced ovarian gonadotoxicity

AU - Tan, Shun Jen

AU - Lee, Li Jen

AU - Tzeng, Chii Ruey

AU - Wang, Chia-Woei

AU - Hsu, Ming I.

AU - Chen, Chi Huang

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Chemotherapy damages the reproductive system by enhancing apoptosis, and evidence suggests that targeted anti-apoptotic therapy may preserve fertility in patients receiving chemotherapy. To investigate the protective effect of sphingosine-1-phosphate (S1P) on chemotherapeutic agent-induced ovarian gonadotoxicity, busulfan-treated female mice were pre-treated with low (0.5 mM) and high (2.0 mM) doses of S1P or vehicle 1 h before busulfan injection. In the S1P groups, each mouse was injected with low-dose S1P in one ovary and high-dose S1P in the contralateral ovary. Four weeks later, the ovaries were removed for histological and biochemical examinations. Caspase 3 immunoreactivity was greater in mice treated with busulfan compared with mice pre-treated with S1P, in which more primordial follicles were observed (P <0.05). The mRNA level of anti-Müllerian hormone was higher in mice pre-treated with S1P than those that received busulfan only, indicating a better ovarian function in mice pre-treated with S1P. No difference was observed in the levels of growth differentiation factor-9 among all groups. In conclusion, S1P protects primordial follicles from chemotherapy-induced gonadotoxicity, and may partially preserve ovarian function.

AB - Chemotherapy damages the reproductive system by enhancing apoptosis, and evidence suggests that targeted anti-apoptotic therapy may preserve fertility in patients receiving chemotherapy. To investigate the protective effect of sphingosine-1-phosphate (S1P) on chemotherapeutic agent-induced ovarian gonadotoxicity, busulfan-treated female mice were pre-treated with low (0.5 mM) and high (2.0 mM) doses of S1P or vehicle 1 h before busulfan injection. In the S1P groups, each mouse was injected with low-dose S1P in one ovary and high-dose S1P in the contralateral ovary. Four weeks later, the ovaries were removed for histological and biochemical examinations. Caspase 3 immunoreactivity was greater in mice treated with busulfan compared with mice pre-treated with S1P, in which more primordial follicles were observed (P <0.05). The mRNA level of anti-Müllerian hormone was higher in mice pre-treated with S1P than those that received busulfan only, indicating a better ovarian function in mice pre-treated with S1P. No difference was observed in the levels of growth differentiation factor-9 among all groups. In conclusion, S1P protects primordial follicles from chemotherapy-induced gonadotoxicity, and may partially preserve ovarian function.

KW - anti-apoptotic therapy

KW - anti-Müllerian hormone

KW - caspase-3

KW - fertility preservation

KW - gonadotoxicity

KW - sphingosine-1-phosphate

UR - http://www.scopus.com/inward/record.url?scp=84908395184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908395184&partnerID=8YFLogxK

U2 - 10.1016/j.rbmo.2014.07.014

DO - 10.1016/j.rbmo.2014.07.014

M3 - Article

C2 - 25246113

AN - SCOPUS:84908395184

VL - 29

SP - 612

EP - 620

JO - Reproductive BioMedicine Online

JF - Reproductive BioMedicine Online

SN - 1472-6483

IS - 5

ER -